MedTrace Logo

Transplantation of Autologous Cardiac Stem Cells in Ischemic Heart Failure

NCT01758406 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-12-04

No results posted yet for this study

Summary

This study is a prospective, randomized, double blind , controlled trial to assess the efficacy of intracoronary transplantation of autologous cardiac stem cells in 50 patients with ischemic heart failure.

Conditions

Interventions

BIOLOGICAL

Intracoronary injection

stem cell transplantation

BIOLOGICAL

Intracoronary injection of Placebo

Injection of Placebo via coronary arteries in patients with heart failure.

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Hamid Gourabi, PhD · Head of Royan Institute

  • Nasser Aghdami, MD,PhD · Head of Royan department of degenerative medicine

  • Ahmad Amin, MD · Department of Heart failure,Shahid Rajaee Hospital

  • Farveh Vakilian, MD · Department of Heart failure , Imam reza hospital, Mashhad, Iran

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-11-30
Completion
2017-12-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01758406 on ClinicalTrials.gov